首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Pharmacokinetic Alteration of Baclofen by Multiple Oral Administration of Herbal Medicines in Rats
【2h】

Pharmacokinetic Alteration of Baclofen by Multiple Oral Administration of Herbal Medicines in Rats

机译:多次口服中草药对大鼠巴氯芬的药代动力学变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The potential pharmacokinetic (PK) interaction of conventional western drug, baclofen, and oriental medications Oyaksungisan (OY) and Achyranthes bidentata radix (AB) extract for the treatment of spasticity has been evaluated. Rats were pretreated with distilled water (DW), OY, or AB extract by oral administration every day for 7 days. After 10 min of the final dose of DW or each herbal medication, baclofen (1 mg/kg) was given by oral administration and plasma concentrations of baclofen were determined by LC/MS/MS. The plasma baclofen concentration-time profiles were then analyzed by noncompartmental analysis and a population PK model was developed. Baclofen was rapidly absorbed, showed biexponential decline with elimination half-life of 3.42–4.10 hr, and mostly excreted into urine. The PK of baclofen was not affected by AB extract pretreatment. However, significantly lower maximum plasma concentration (C max) and longer time to reach C max (T max) were observed in OY pretreated rats without changes in the area under the curve (AUC) and the fraction excreted into urine (F urine). The absorption rate (K a) of baclofen was significantly decreased in OY pretreated rats. These data suggested that repeated doses of OY might delay the absorption of baclofen without changes in extent of absorption, which needs further evaluation for clinical significance.
机译:已评估了常规西药,巴氯芬和东方药物Oyaksungisan(OY)和牛膝草(AB)提取物治疗痉挛的潜在药代动力学(PK)相互作用。每天口服给予大鼠蒸馏水(DW),OY或AB提取物预处理,持续7天。 DW或每种草药的最终剂量10分钟后,口服巴氯芬(1微克/千克),并通过LC / MS / MS测定巴氯芬的血浆浓度。然后通过非房室分析法分析血浆巴氯芬浓度-时间曲线,并建立了种群PK模型。巴氯芬被迅速吸收,表现出双指数下降,消除半衰期为3.42–4.10 hr,大部分排泄到尿液中。 BAclofen的PK不受AB提取物预处理的影响。然而,在OY预处理的大鼠中观察到明显降低的最大血浆浓度(C max)和更长的时间达到C max(T max),而曲线下面积(AUC)却没有变化,并且馏分排入尿液(F尿)。 OY预处理的大鼠中巴氯芬的吸收率(K a)显着降低。这些数据表明,重复剂量的OY可能会延迟巴氯芬的吸收而不会改变吸收程度,这需要进一步评估其临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号